Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

TMBR Financial Statements and Analysis

AMEX : TMBR

Timber Pharmaceuticals, Inc.

$0.34
0.0025+0.74%
At Close 4:00 PM
Not Actively Trading
75.64
BESG ScoreESG Rating

TMBR FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

TMBR Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateJun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202220222022
periodQ2Q1Q4Q3Q2
revenue0083.177K00
cost of revenue2.471M2.366M000
gross profit-2.471M-2.366M83.177K00
gross profit ratio001.0000
research and development expenses2.471M2.366M2.101M1.791M7.892M
general and administrative expenses1.37M0000
selling and marketing expenses00000
selling general and administrative expenses1.37M1.635M1.465M1.337M1.512M
other expenses157.421K083.177K04.00M
operating expenses3.841M4.00M3.566M3.127M9.404M
cost and expenses3.841M4.00M3.566M3.127M9.404M
interest income13.836K62.977K2.445K00
interest expense65.098K62.977K60.925K71.203K42.077K
depreciation and amortization88.091K87.464K88.594K83.20K80.256K
ebitda-3.739M-3.913M-3.478M-3.044M-9.324M
ebitda ratio00-41.80900
operating income-3.999M-4.00M-3.566M-3.127M-9.404M
operating income ratio00-42.87500
total other income expenses net-170.756K-60.822K-49.005K-60.079K-92.153K
income before tax-4.063M-4.061M-3.615M-3.187M-9.496M
income before tax ratio00-43.46400
income tax expense65.098K123.799K7.60K-11.124K50.076K
net income-4.063M-4.185M-3.623M-3.176M-9.546M
net income ratio00-43.55500
eps-1.32-1.36-1.72-1.52-7.49
eps diluted-1.32-1.36-1.72-1.52-7.49
weighted average shs out3.078M3.078M2.108M2.095M1.275M
weighted average shs out dil3.081M3.078M2.108M2.095M1.275M
Graph

TMBR Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateJun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202220222022
periodQ2Q1Q4Q3Q2
cash and cash equivalents2.52M5.175M9.08M11.224M8.274M
short term investments00000
cash and short term investments2.52M5.175M9.08M11.224M8.274M
net receivables00000
inventory00000
other current assets132.766K116.162K207.171K296.038K237.158K
total current assets2.791M5.496M9.813M12.242M9.279M
property plant equipment net389.971K635.484K335.305K420.318K503.517K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets145.137K145.137K127.534K127.534K127.534K
total non current assets535.108K780.621K462.839K547.852K631.051K
other assets00000
total assets3.326M6.277M10.276M12.79M9.91M
account payables1.632M1.014M1.351M953.47K420.353K
short term debt222.336K327.266K331.152K336.162K341.308K
tax payables163.408K163.408K000
deferred revenue00000
other current liabilities3.771M3.326M3.36M3.71M5.811M
total current liabilities5.625M4.668M5.041M5.00M6.572M
long term debt322.793K298.164K083.52K163.985K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities001.682M73.683K1.824M
total non current liabilities322.793K298.164K1.682M157.203K1.988M
other liabilities00-1.682M00
capital lease obligations545.129K625.43K331.152K419.682K505.293K
total liabilities5.947M4.966M5.041M5.157M8.56M
preferred stock00002.152M
common stock148.432K148.392K148.354K133.543K63.754K
retained earnings-56.389M-52.325M-48.264M-44.641M-41.454M
accumulated other comprehensive income loss00000
other total stockholders equity53.619M53.488M53.35M52.141M40.588M
total stockholders equity-2.621M1.311M5.234M7.633M1.35M
total equity-2.621M1.311M5.234M7.633M1.35M
total liabilities and stockholders equity3.326M6.277M10.276M12.79M9.91M
minority interest00000
total investments00000
total debt545.129K625.43K331.152K419.682K505.293K
net debt-1.974M-4.55M-8.749M-10.805M-7.768M
Graph

TMBR Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202220222022
periodQ2Q1Q4Q3Q2
deferred income tax0-70.806K-327.455K00
stock based compensation131.504K137.526K172.557K224.547K283.927K
change in working capital1.03M-66.719K170.037K-1.265M1.756M
accounts receivables00000
inventory00000
accounts payables617.308K-336.506K397.325K533.117K-398.459K
other working capital413.042K336.506K-227.288K-1.798M2.154M
other non cash items157.421K70.806K327.455K12.263K1.792M
net cash provided by operating activities-2.656M-3.903M-3.194M-4.132M-5.584M
investments in property plant and equipment1.00-1.961K-1.137K0-2.428K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites1.00-1.961K-1.137K0-2.428K
debt repayment00000
common stock issued001.051M00
common stock repurchased00000
dividends paid00000
other financing activites0007.082M0
net cash used provided by financing activities001.051M7.082M0
effect of forex changes on cash00000
net change in cash-2.656M-3.905M-2.144M2.95M-5.587M
cash at end of period2.52M5.175M9.08M11.224M8.274M
cash at beginning of period5.175M9.08M11.224M8.274M13.86M
operating cashflow-2.656M-3.903M-3.194M-4.132M-5.584M
capital expenditure1.00-1.961K-1.137K0-2.428K
free cash flow-2.656M-3.905M-3.195M-4.132M-5.587M
Graph

Frequently Asked Questions

How did Timber Pharmaceuticals, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, TMBR generated $0.00 in revenue last quarter, while its costs came in at $2.47M.
Last quarter, how much Gross Profit did Timber Pharmaceuticals, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Timber Pharmaceuticals, Inc. reported a -$2.47M Gross Profit for the quarter ended Jun 30, 2023.
Have TMBR's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. TMBR incurred $3.84M worth of Operating Expenses, while it generated -$4.00M worth of Operating Income.
How much Net Income has TMBR posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Timber Pharmaceuticals, Inc., the company generated -$4.06M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Timber Pharmaceuticals, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Timber Pharmaceuticals, Inc. as of the end of the last quarter was $2.52M.
What are TMBR's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, TMBR had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Timber Pharmaceuticals, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of TMBR were $2.79M, while the Total Assets stand at $3.33M.
As of the last quarter, how much Total Debt did Timber Pharmaceuticals, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of TMBR's debt was $545.13K at the end of the last quarter.
What were TMBR's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, TMBR reported total liabilities of $5.95M.
How much did TMBR's Working Capital change over the last quarter?
Working Capital Change for TMBR was $1.03M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
TMBR generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. TMBR generated -$2.66M of Cash from Operating Activities during its recently reported quarter.
What was TMBR's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. TMBR reported a -$2.66M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph